- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03847753
Exploring the Comorbidity Between Mental Disorders and General Medical Conditions (COMO-GMC)
Exploring the Comorbidity Between Mental Disorders and General Medical Conditions Among a Danish National Population
Mental disorders have been shown to be associated with a number of general medical conditions (also referred to as somatic or physical conditions). The investigators aim to undertake a comprehensive study of comorbidity among those with treated mental disorders, by using high-quality Danish registers to provide age- and sex-specific pairwise estimates between the ten groups of mental disorders and nine groups of general medical conditions.
The investigators will examine the association between all 90 possible pairs of prior mental disorders and later GMC categories using the Danish national registers. Depending on whether individuals are diagnosed with a specific mental disorder, the investigators will estimate the risk of receiving a later diagnosis within a specific GMC category, between the start of follow-up (January 1, 2000) or at the earliest age at which a person might develop the mental disorder, whichever comes later. Follow-up will be terminated at onset of the GMC, death, emigration from Denmark, or December 31, 2016, whichever came first. Additionally for dyslipidemia, follow-up will be ended if a diagnosis of ischemic heart disease was received. A "wash-out" period will be employed in the five years before follow-up started (1995-1999), to identify and exclude prevalent cases from the analysis. Individuals with the GMC of interest before the observation period will be considered prevalent cases and excluded from the analyses (i.e. prevalent cases were "washed-out"). When estimating the risk of a specific GMC, the investigators will consider all individuals to be exposed or unexposed to the each mental disorder depending on whether a diagnosis is received before the end of follow-up. Persons will be considered unexposed to a mental disorder until the date of the first diagnosis, and exposed thereafter.
Study Overview
Status
Conditions
- Heart Failure
- Stroke
- Epilepsy
- Pain
- Multiple Sclerosis
- Hypertension
- Diabetes Mellitus
- Cancer
- Chronic Kidney Diseases
- Schizophrenia
- Parkinson Disease
- Migraine
- Inflammatory Bowel Diseases
- Anemia
- HIV/AIDS
- Atrial Fibrillation
- Dyslipidemias
- Allergy
- Osteoporosis
- Ischemic Heart Disease
- Hearing Disorders
- Substance Use
- Vision Disorders
- Neuropathy
- Gout
- Chronic Liver Disease
- Mental Retardation
- Eating Disorder
- Chronic Pulmonary Disease
- Chronic Gastritis
- Connective Tissue Disorder
- Thyroid Disorder
- Neurotic, Stress-related and Somatoform Disorders
- Disorders of Adult Personality and Behavior
- Organic, Including Symptomatic, Mental Disorders
- Mood [Affective] Disorders
- Disorder of Psychological Development
- Behavioural Disorder
- Peripheral Occlusive Disease
- Diverticular Disease of Large Intestine
- Prostate Disorders
Intervention / Treatment
Detailed Description
The investigators will analyse data from all individuals born in Denmark between 1900-2015 and who resided there between 2000-2016; giving a study size of over 5.5 million people. The National Patient Register, Cause of Death Register and National Prescription Registry of Denmark will all be used as sources of information about the mental disorders and general medical conditions (GMC) of interest. These are considered to be of high quality and validity.
The rate of diagnosis with a specific GMC group between those exposed and unexposed to each of ten mental disorders will be examined using hazard ratios (HRs) and 95% confidence intervals (CI), using Cox proportional hazards models with age as the underlying time scale. The following models will be run to provide all persons and sex-specific estimates, considering exposure to each mental disorder and whether the association differs depending on the time since onset of the mental disorder (lagged HRs):
Model A: adjusted for sex and birth date which, in combination with underlying age in the models, adjusts also for calendar time
Model B: additionally adjust for mental disorder comorbidity with onset before, but not after, the mental disorder of interest
Finally, cumulative incidence proportions of diagnosis with a GMC after being diagnosed with a mental disorder will be estimated. This will provide absolute risks of developing a GMC after a specific time, given a previous diagnosis of a mental disorder. To compare cumulative incidence proportions among people diagnosed with a mental disorder to those among people without a diagnosis, a matched reference group will be generated for each mental disorder. For every index person with the mental disorder, up to five age- and sex-matched individuals (who had not received a diagnosis of the relevant mental disorder by the age the index person was diagnosed) will be randomly selected. Cumulative incidence proportions will be generated for each reference group. All analyses will be performed on the secured platform of Statistics Denmark STATA/MP version 15.1 (Stata Corporation, College Station, Texas, USA).
An interactive webpage will be developed to visualize all results from this study. The Danish Data Protection Agency and the Danish Health Data Authority approved this study.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Born in Denmark between 1900-2015
- Resided in Denmark during the study period (2000-2016)
Exclusion Criteria:
- Excluded from analyses for each specific GMC, if considered a prevalent case of that GMC (i.e. ascertained to have a diagnosis for the GMC during the washout period of 1995-1999)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Danish population
The cohort includes all those born in Denmark between 1900-2015, and who resided there in the period of 2000-2016.Whether they received a diagnosis of one of the following mental disorders will be ascertained: Organic Disorders, Substance Use Disorders, Schizophrenia Disorders, Mood Disorders, Eating Disorders, Neurotic Disorders, Personality Disorders, Intellectual Disorders, Developmental Disorders, Behavioral Disorders The risk of receiving a later diagnosis of one of the following types of general medical conditions will then be estimated: Circulatory, Endocrine, Pulmonary and Allergy, Gastrointestinal, Urogenital, Musculoskeletal, Hematological, Cancer, Neurological
|
Individuals were considered to have a specific mental disorder from the date they received a relevant diagnosis registered in the Danish Psychiatric Central Research Register.
Individuals were considered to have a specific mental disorder from the date they received a relevant diagnosis registered in the Danish Psychiatric Central Research Register.
Individuals were considered to have a specific mental disorder from the date they received a relevant diagnosis registered in the Danish Psychiatric Central Research Register.
Individuals were considered to have a specific mental disorder from the date they received a relevant diagnosis registered in the Danish Psychiatric Central Research Register.
Individuals were considered to have a specific mental disorder from the date they received a relevant diagnosis registered in the Danish Psychiatric Central Research Register.
Individuals were considered to have a specific mental disorder from the date they received a relevant diagnosis registered in the Danish Psychiatric Central Research Register.
Individuals were considered to have a specific mental disorder from the date they received a relevant diagnosis registered in the Danish Psychiatric Central Research Register.
Individuals were considered to have a specific mental disorder from the date they received a relevant diagnosis registered in the Danish Psychiatric Central Research Register.
Individuals were considered to have a specific mental disorder from the date they received a relevant diagnosis registered in the Danish Psychiatric Central Research Register.
Individuals were considered to have a specific mental disorder from the date they received a relevant diagnosis registered in the Danish Psychiatric Central Research Register.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Risk of circulatory system general medical conditions
Time Frame: Diagnosed during the study period (2000-2016), after at least 1 year of age
|
These will be ascertained using the following criteria: Diagnosis in the Danish National Patient Register or death in the Cause of Death register, for at least one of the following diseases: hypertension, dyslipidemia, ischemic heart disease, atrial fibrillation, heart failure, peripheral arterial occlusive disease, stroke. Records in the Danish National Prescription Register for at least one of the following types of medications: antihypertensives, lipid-lowering drugs, antianginal drugs (at least two prescriptions for a type of medication in one year). Hazard ratios (HRs), with 95% confidence intervals, will be obtained to compare risk of diagnosis with a general medical condition in those with previous mental disorders, compared to those without. All persons, sex-specific and lagged (accounting for time since mental disorder diagnosis) HRs will be obtained. Additionally absolute risks will be calculated. |
Diagnosed during the study period (2000-2016), after at least 1 year of age
|
Risk of Endocrine System general medical conditions
Time Frame: Diagnosed during the study period (2000-2016), after at least 1 year of age
|
These will be ascertained using the following criteria: Diagnosis in the Danish National Patient Register or death in the Cause of Death register, for at least one of the following diseases: diabetes mellitus, thyroid disorders, gout. Records in the Danish National Prescription Register for at least one of the following types of medications: antidiabetic, thyroid therapy drugs (at least two prescriptions for a type of medication in one year). Hazard ratios (HRs), with 95% confidence intervals, will be obtained to compare risk of diagnosis with a general medical condition in those with previous mental disorders, compared to those without. All persons, sex-specific and lagged (accounting for time since mental disorder diagnosis) HRs will be obtained. Additionally absolute risks will be calculated. |
Diagnosed during the study period (2000-2016), after at least 1 year of age
|
Risk of Pulmonary System general medical conditions
Time Frame: Diagnosed during the study period (2000-2016), after at least 1 year of age
|
These will be ascertained using the following criteria: Diagnosis in the Danish National Patient Register or death in the Cause of Death register, for at least one of the following diseases: chronic pulmonary disease, allergy. Records in the Danish National Prescription Register for at least one of the following types of medications: obstructive airway disease drugs, non-sedative antihistamines and/or nasal antiallergics (at least two prescriptions for a type of medication in one year). Hazard ratios (HRs), with 95% confidence intervals, will be obtained to compare risk of diagnosis with a general medical condition in those with previous mental disorders, compared to those without. All persons, sex-specific and lagged (accounting for time since mental disorder diagnosis) HRs will be obtained. Additionally absolute risks will be calculated. |
Diagnosed during the study period (2000-2016), after at least 1 year of age
|
Risk of Gastrointestinal System general medical conditions
Time Frame: Diagnosed during the study period (2000-2016), after at least 1 year of age
|
These will be ascertained using the following criteria: Diagnosis in the Danish National Patient Register or death in the Cause of Death register, for at least one of the following diseases: ulcer/chronic gastritis, chronic liver disease, inflammatory bowel disease, diverticular disease of intestine. Hazard ratios (HRs), with 95% confidence intervals, will be obtained to compare risk of diagnosis with a general medical condition in those with previous mental disorders, compared to those without. All persons, sex-specific and lagged (accounting for time since mental disorder diagnosis) HRs will be obtained. Additionally absolute risks will be calculated. |
Diagnosed during the study period (2000-2016), after at least 1 year of age
|
Risk of Urogenital System general medical conditions
Time Frame: Diagnosed during the study period (2000-2016), after at least 1 year of age
|
These will be ascertained using the following criteria: Diagnosis in the Danish National Patient Register or death in the Cause of Death register, for at least one of the following diseases: chronic kidney disease, prostate disorders. Records in the Danish National Prescription Register for at least one of the following types of medications: prostate hyperplasia therapy drugs (at least two prescriptions for a type of medication in one year). Hazard ratios (HRs), with 95% confidence intervals, will be obtained to compare risk of diagnosis with a general medical condition in those with previous mental disorders, compared to those without. All persons, sex-specific and lagged (accounting for time since mental disorder diagnosis) HRs will be obtained. Additionally absolute risks will be calculated. |
Diagnosed during the study period (2000-2016), after at least 1 year of age
|
Musculoskeletal System general medical conditions
Time Frame: Diagnosed during the study period (2000-2016), after at least 1 year of age
|
These will be ascertained using the following criteria: Diagnosis in the Danish National Patient Register or death in the Cause of Death register, for at least one of the following diseases: connective tissue disorders, osteoporosis. Records in the Danish National Prescription Register for at least one of the following types of medications: osteoporosis drugs (at least two prescriptions for a type of medication in one year) or repeated prescriptions for analgesics (at least four times in one year). Hazard ratios (HRs), with 95% confidence intervals, will be obtained to compare risk of diagnosis with a general medical condition in those with previous mental disorders, compared to those without. All persons, sex-specific and lagged (accounting for time since mental disorder diagnosis) HRs will be obtained. Additionally absolute risks will be calculated. |
Diagnosed during the study period (2000-2016), after at least 1 year of age
|
Risk of Neurological System general medical conditions
Time Frame: Diagnosed during the study period (2000-2016), after at least 1 year of age
|
These will be ascertained using the following criteria: Diagnosis in the Danish National Patient Register or death in the Cause of Death register, for at least one of the following diseases: vision problems, hearing problems, migraine, epilepsy*, Parkinson's Disease, multiple sclerosis, neuropathies. Records in the Danish National Prescription Register for at least one of the following types of medications: specific anti-migraine drugs, antiepileptic drugs* (at least two prescriptions for a type of medication in one year) *Both a diagnosis of epilepsy AND two prescriptions of an antiepileptic drug in one year are required. Hazard ratios (HRs), with 95% confidence intervals, will be obtained to compare risk of diagnosis with a general medical condition in those with previous mental disorders, compared to those without. All persons, sex-specific and lagged (accounting for time since mental disorder diagnosis) HRs will be obtained. Additionally absolute risks will be calculated. |
Diagnosed during the study period (2000-2016), after at least 1 year of age
|
Risk of Hematological System general medical conditions
Time Frame: Diagnosed during the study period (2000-2016), after at least 1 year of age
|
These will be ascertained using the following criteria: Diagnosis in the Danish National Patient Register or death in the Cause of Death register, for at least one of the following diseases: HIV/AIDS, anemias. Hazard ratios (HRs), with 95% confidence intervals, will be obtained to compare risk of diagnosis with a general medical condition in those with previous mental disorders, compared to those without. All persons, sex-specific and lagged (accounting for time since mental disorder diagnosis) HRs will be obtained. Additionally absolute risks will be calculated. |
Diagnosed during the study period (2000-2016), after at least 1 year of age
|
Risk of Cancers
Time Frame: Diagnosed during the study period (2000-2016), after at least 1 year of age
|
These will be ascertained using the following criteria: Cancer diagnosis in the Danish National Patient Register or death in the Cause of Death register. Hazard ratios (HRs), with 95% confidence intervals, will be obtained to compare risk of diagnosis with a general medical condition in those with previous mental disorders, compared to those without. All persons, sex-specific and lagged (accounting for time since mental disorder diagnosis) HRs will be obtained. Additionally absolute risks will be calculated. |
Diagnosed during the study period (2000-2016), after at least 1 year of age
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: John J McGrath, MD, PhD, National Centre for Register-Based Research, Aarhus University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Chemically-Induced Disorders
- Digestive System Diseases
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Metabolic Diseases
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Immune System Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Demyelinating Autoimmune Diseases, CNS
- Autoimmune Diseases of the Nervous System
- Demyelinating Diseases
- Autoimmune Diseases
- Urologic Diseases
- Eye Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Gastrointestinal Diseases
- Stomach Diseases
- Renal Insufficiency
- Musculoskeletal Diseases
- Schizophrenia Spectrum and Other Psychotic Disorders
- Gastroenteritis
- Otorhinolaryngologic Diseases
- Parkinsonian Disorders
- Basal Ganglia Diseases
- Movement Disorders
- Synucleinopathies
- Neurodegenerative Diseases
- Intestinal Diseases
- Ear Diseases
- Pathological Conditions, Anatomical
- Arrhythmias, Cardiac
- Coronary Disease
- Bone Diseases
- Lipid Metabolism Disorders
- Sensation Disorders
- Neurodevelopmental Disorders
- Bone Diseases, Metabolic
- Substance-Related Disorders
- Liver Diseases
- Heart Diseases
- Coronary Artery Disease
- Myocardial Ischemia
- Multiple Sclerosis
- Kidney Diseases
- Renal Insufficiency, Chronic
- Schizophrenia
- Gastritis
- Disease
- Psychotic Disorders
- Parkinson Disease
- Inflammatory Bowel Diseases
- Atrial Fibrillation
- Feeding and Eating Disorders
- Mental Disorders
- Dyslipidemias
- Somatoform Disorders
- Mood Disorders
- Osteoporosis
- Connective Tissue Diseases
- Intellectual Disability
- Hearing Disorders
- Vision Disorders
- Diverticulum
- Diverticular Diseases
Other Study ID Numbers
- COMO-GMC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
US Department of Veterans AffairsCompleted
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on Organic Disorders
-
King's College LondonCompletedHealthy Men and WomenUnited Kingdom
-
Bellamy's Organic Pty LtdActive, not recruitingInfant DevelopmentChina
-
Bobbie Baby, IncRecruitingHealthy GrowthUnited States
-
Medical University of GrazRecruitingMicrobial Colonization | Neuroblastoma | Children, OnlyAustria
-
Hopital FochCompleted
-
Hasanuddin UniversityArla FoodsCompletedFood Allergy in InfantsIndonesia
-
Sansum Diabetes Research InstituteUnited States Department of Agriculture (USDA)TerminatedObesity | Diabetes Mellitus, Type 2 | Food Supply | Minority Health | PovertyUnited States
-
Hopital FochRecruiting
-
Boise State UniversityNational Institute of Environmental Health Sciences (NIEHS)CompletedExposure to HerbicidesUnited States
-
University of CopenhagenCompleted